Abstract:Liposomes-based anticancer drug delivery system has been developed and widely used in clinical tumor therapy. In addition, active targeting strategies were proposed, in which antibodies or targeting ligands ware used to direct the liposomes to further encourage the interaction between drug loaded liposomes and tumors. Obviously, the density and conformation of the targeting ligand on the surface of the liposome have huge effects on its targeting efficiency in vivo. However, there is no last word about their relation or possible optimum conditions. So the purpose of this study is to establish a quantitative method to analyze the targeting ligand density on the surface of targeted liposomes, and to investigate the effect of different ligand density on the liposome distribution pattern in tumor-bearing mice. The peptide ligand-conjugated lipids were incorporated onto the liposome surface by the post incubation method. The surface-modified liposomes and free ligands ware separated by size exclusion chromatography and then the exact lipid compositions were determined using HPLC-ELSD method. The in vivo distribution of the targeted liposomes in H460 xenegraft tumor-beadng mice ware monitored using an eXplore Optix in vivo fluorescence imaging system (GE Healthcare). The images were processed and the tumor fluorescence intensities were analyzed using Kinetica 5.0 (trial version, Thermo Fisher). Liposomes containing surface 134 peptide modifications ware made by incubation with different molar ratios (2:100, 3:100, 4:100 and 5:100) of the peptide-conjugated lipids. The resulted peptide surface densities ware (0.764± 0.047)%, (0.935±0.069)%, (1.298±0.093)% and (1.594±0.028)%. After tail vein injection, the fluorescence intensity in the tumor had T_(1/2) of 67.39 h, 83.38 h, 98.69 h and 104.81 h. The mean residence times were 97.20 h, 117.42 h, 142.11 h and 150.86 h. The results indicated that with the increase of ligand density on the surface of targeted liposomes, the AUC, T_(1/2), and MRT of fluorescence intensities at tumor site showed a trend of increasing. When the ligand density was higher than 1.298%, the targeted liposomes had larger value of AUC, T_(1/2), and MRT than non-modified liposomes. These data suggested that the targeting ligand designed on basis of receptor-ligand recognization mechanism showed its advantages when the targeted liposomes had higher surface ligand density.

The Study of Liposome Surface Ligand Density on Its Targeting Efficiency in Vivo

Quantification of Available Ligand Density on the Surface of Targeted Liposomal Nanomedicines at the Single-Particle Level

Effect of Surface Ligand Density on Cytotoxicity and Pharmacokinetic Profile of Docetaxel Loaded Liposomes

Effect of Ligand Density and PEG Modification on Octreotide-Targeted Liposome Via Somatostatin Receptor in Vitro and in Vivo

Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.

Study on Tumor Targeting Ability of Neovessel-Targeted PEGylated Liposomes

Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency

Microfluidic Self-Assembly of a Combinatorial Library of Single- and Dual-Ligand Liposomes for in Vitro and in Vivo Tumor Targeting

Increased Tumor Targeted Delivery Using a Multistage Liposome System Functionalized with RGD, TAT and Cleavable PEG.

Synergistic Targeted Delivery of Payload into Tumor Cells by Dual-Ligand Liposomes Co-Modified with Cholesterol Anchored Transferrin and TAT.

Effect of Octreotide Surface Density on Receptor-Mediated Endocytosis in Vitro and Anticancer Efficacy of Modified Nanocarrier in Vivo after Optimization

The Targeted-liposome Delivery System of Antitumor Drugs

Tumor-targeted Liposomal Drug Delivery Mediated by a Diseleno Bond-Stabilized Cyclic Peptide

Boosting the Theranostic Effect of Liposomal Probes Toward Prominin-1 Through Optimized Dual-Site Targeting

Surface Ligand Valency and Immunoliposome Binding: when More is Not Always Better

Comparison of two methods for tumour-targeting peptide modification of liposomes

Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer

Comparative Study of the in Vitro and in Vivo Characteristics of Cationic and Neutral Liposomes.

Preparation and Anti-tumor Activity Evaluation of LyP-1-conjugated Liposomes for Tumor Targeting Drug Delivery

The effects of ligand distribution and density on the targeting properties of dual-targeting folate/biotin Pluronic F127/Poly (lactic acid) polymersomes

Effect of Size and Pegylation of Liposomes and Peptide-Based Synthetic Lipoproteins on Tumor Targeting.